Pre-IPO Transcenta Holding - Insights on Pipeline and the Concerns
The article mainly analyzed Transcenta Holding in terms of its important product candidates MSB2311, TST001, TST005 and MSB0254,including the...
226 Views
Transcenta (创胜) Pre-IPO: Thoughts on Valuation
We provide a pre-money valuation for Transcenta's key products, including MSB2311 (next generation PD-L1) and TST001 (Claudin 18.2) in this note.
315 Views
ECM Weekly (4th July 2021) - Xpeng, Medbot, Medlive, Brii Bio, CTOS, LinkDoc, Devyani, Manycore
Aequitas Research puts out a weekly update on the deals that have been covered by the team recently along with updates for upcoming IPOs.
412 Views
Transcenta (创胜) Pre-IPO: Buy the Experienced Team
Formerly Mabspace, we think Transcenta has an experienced team with with innovative product though the immediate addressable market is not huge.
467 Views